Recent Quotes

You have no recent quotes

Sector: Health Care.Industry: Pharmaceuticals

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-07-29
REV		(EXPECTED)2021-07-29

Q1 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-06-29
REV		(EXPECTED)2021-06-29

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
PPBT	Purple Biotech	5.12	-0.04	-0.76%

Purple Biotech Frequently Asked Questions

How do I buy Purple Biotech (PPBT) stock?

You can purchase shares of Purple Biotech (NASDAQ: PPBT) through any online brokerage.

View our list of the best stock brokerages.

Who are Purple Biotech's (PPBT) competitors?

Other companies in Purple Biotech’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).

What is the target price for Purple Biotech (PPBT) stock?

There is no analysis for Purple Biotech

Current Stock Price for Purple Biotech (PPBT)?

The stock price for Purple Biotech (NASDAQ: PPBT) is $5.16 last updated Mon Jun 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Purple Biotech (PPBT) pay a dividend?

There are no upcoming dividends for Purple Biotech.

When is Purple Biotech (NASDAQ:PPBT) reporting earnings?

Purple Biotech’s Q2 earnings are confirmed for after-market on July 29, 2021.

Is Purple Biotech (PPBT) going to split?

There is no upcoming split for Purple Biotech.

What sector and industry does Purple Biotech (PPBT) operate in?

Purple Biotech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.